Patients who reached the target PBG using this protocol(N = 14) | Patients who failed to reach the target PBG | ||
---|---|---|---|
â‘ | â‘¡ | ||
Age (years) | 67.0 (55.5-70.5) | 78 | 61 |
Sex (men/women) | 10/4 | man | woman |
BMI (kg/m2) | 25.0 (21.8-27.8) | 28.0 | 22.1 |
Duration of diabetes (years) | 13.0 (7.0-21.5) | 12 | 40 |
HbA1c (%) | 9.2 (8.7-11.2) | 8.3 | 8.2 |
Glycated albumin (%) | 23.0 (20.2-29.4) | 21.1 | 19.8 |
eGFR (mL/min/1.73 m2) | 70.5 (58–84.2) | 70.0 | 67.2 |
Urinary C-peptide excretion (μg/day) | 43.5 (24.8-69.6) | 67.4 | 14.4 |
C-peptide | |||
(Glucagon stimulated test) | |||
at 0 minutes (ng/mL) | 0.9 (0.75-1.45) | 1.9 | 0.4 |
at 6 minutes (ng/mL) | 2.3 (1.45-2.9) | 3.0 | 0.8 |
Δ (ng/mL) | 1.1 (0.65-1.40) | 1.1 | 0.4 |
Insulin glargine (units/day) | 14 (8.5-18.5) | 12 | 13 |
Insulin glargine (units/kg) | 0.2 (0.17-0.26) | 0.15 | 0.23 |
MAGE at the final CGM evaluation | 60.5 (46.9-69.2) | 61.3 | 87.6 |
(N = 12) | |||
M-value at the final SMBG evaluation | 8.4 (4.3-14.1) | 24.2 | 18.0 |